Medtech Insights

Growth in the US market for gynecological devices will be driven primarily by growing adoption of hormonal IUDs, hysteroscopic morcellators, and ARC devices. The market will also be fueled by…

Despite the negative—albeit relatively limited—impact of the ongoing COVID-19 pandemic, the Asia Pacific interventional oncology device market will see strong growth through 2030 driven by…

Despite the impact of the ongoing COVID-19 pandemic, the Asia Pacific gynecological device market will continue to expand through 2030 due to growing patient awareness of gynecologic treatments…

Growing AF treatment volumes, driven by an expanding patient pool, rising awareness of ablation procedures, and improving access to health care, will fuel strong growth in the Asia Pacific EP …

The COVID-19 pandemic will negatively impact the Asia Pacific GI endoscopy device market. Once the market stabilizes, however, it will expand quickly through 2029, primarily driven by the …

Procedure deferrals due to the COVID-19 pandemic severely impacted the Asia Pacific GI endoscopy device market, and the elective nature of many postponed procedures will hinder the pace of…

The Asia Pacific heart valve device market has seen a moderately negative impact due to the global COVID-19 pandemic. However, in the long term, the market will be driven by positive results from…

Although the COVID-19 pandemic will have a significant impact on the Asia Pacific aesthetic injectable market in the short term, the market will grow rapidly through 2030. Recovery of the…

The COVID-19 pandemic will have a significant impact on ENT procedure volumes as growing developments in alternative treatment such as antibiotics and the continued effort of various…

While the COVID-19 pandemic will negatively impact the Asia Pacific market for aortic repair devices in the short term, the market  for aortic repair devices will expand at a modest rate over the…

Despite the negative, albeit limited, impact of the COVID-19 pandemic in the short term, the Asia Pacific market for neurovascular devices will grow moderately, driven by improving healthcare…

The Asia Pacific dialysis access treatment device market will grow modestly through 2029, driven by rising incidence of ESRD due to the aging population, coupled with government initiatives to…